The criteria for mild cognitive impairment due to Alzheimer's disease (AD) and preclinical AD, while offering great hope of fostering research on primary and secondary prevention for AD, are currently unsuitable for use in general clinical practice and must be used with great caution in specialized memory clinics.
No takes yet. Share an insight, caveat, or question.
Gauthier et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: